BioMarin Pharmaceutical | Текущие Активы



Current Assets Изменить Дата
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Bayer EUR 34.44B 1.31B 2024-12
Biogen USD 7.63B 169.2M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Incyte USD 3.23B 7.24M 2025-03
Insmed USD 1.62B 28.18M 2024-12
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
PTC Therapeutics USD 2.32B 950.88M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 42.59B 12.51B 2024-12
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



BioMarin Pharmaceutical Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.